On ECHEMI
Home > Drugs > Suzhou First Pharmacertical Co., Ltd.
Suzhou First Pharmacertical Co., Ltd.
  • Founded in:

    2005-12-23
  • Country:

    China China
  • Address:

    No. 1 Hualing Street, Suzhou Industrial Park
  • Tax NO.:

    91320594783360722P
  • Registered Funds:

    181.625 million yuan
  • Email:

Related Drugs
Methylphenidate hydrochloride tablets
The main ingredient of this product is: methylphenidate hydrochloride.
Name Description Content CAS NO. Registered Holders
Methylphenidate hydrochloride

Unspecified

More

Unspecified

0
Tiapride Hydrochloride Tablets
The main ingredient of this product is tiapride hydrochloride.
Name Description Content CAS NO. Registered Holders
Tiapride hydrochloride

This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect.

More

This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect.

51012-33-0 11
Compound Glycyrrhizic Acid Monoammonium S for Injection
This product is a compound preparation, its components are: glycyrrhizic acid, cysteine hydrochloride, and glycine.
Name Description Content CAS NO. Registered Holders
Glycyrrhizic acid

Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman Phenomenon and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymus atrophy effects. (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman Phenomenon and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymus atrophy effects. (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

1405-86-3 1
L-Cysteine monohydrochloride

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

52-89-1 11
Glycine

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

More

1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.

56-40-6 27
Pentoxifylline for injection
alpha;-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha;-isopropylbenzeneacetonitrile hydrochloride Molecular formula: C27H38N2O4.HCL Molecular weight: 491.07
Name Description Content CAS NO. Registered Holders
(+/-)-Verapamil hydrochloride

1. Calcium ion antagonist, regulates calcium ion influx but does not change serum calcium concentration; 2. Dilates the main coronary arteries and arterioles, antagonizes coronary artery spasm, and increases myocardial oxygen delivery; 3. Reduces total peripheral resistance and lowers myocardial oxygen consumption; 4. Prolongs the effective refractory period of the atrioventricular node, slows conduction, and reduces the ventricular rate in patients with chronic atrial fibrillation and atrial flutter; 5. Produces a hypotensive effect by reducing systemic vascular resistance; 6. Reduces afterload, inhibits myocardial contraction, and improves left ventricular diastolic function; 7. Animal experiments show local anesthetic effects; 8. Verapamil is non-carcinogenic and non-mutagenic.

More

1. Calcium ion antagonist, regulates calcium ion influx but does not change serum calcium concentration; 2. Dilates the main coronary arteries and arterioles, antagonizes coronary artery spasm, and increases myocardial oxygen delivery; 3. Reduces total peripheral resistance and lowers myocardial oxygen consumption; 4. Prolongs the effective refractory period of the atrioventricular node, slows conduction, and reduces the ventricular rate in patients with chronic atrial fibrillation and atrial flutter; 5. Produces a hypotensive effect by reducing systemic vascular resistance; 6. Reduces afterload, inhibits myocardial contraction, and improves left ventricular diastolic function; 7. Animal experiments show local anesthetic effects; 8. Verapamil is non-carcinogenic and non-mutagenic.

152-11-4 13
ATP-Coenzyme Insulin for Injection
Name Description Content CAS NO. Registered Holders
ADENOSINE 5'-TRIPHOSPHATASE

It directly participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotide in the body, supplies energy to the body, promotes the recovery of damaged cell function, activates organ function and enhances the body's immunity.

More

It directly participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotide in the body, supplies energy to the body, promotes the recovery of damaged cell function, activates organ function and enhances the body's immunity.

9000-83-3 0
Coenzyme A

It directly participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotide in the body, supplies energy to the body, promotes the recovery of damaged cell function, activates organ function and enhances the body's immunity.

More

It directly participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotide in the body, supplies energy to the body, promotes the recovery of damaged cell function, activates organ function and enhances the body's immunity.

85-61-0 4
INSULIN

It promotes the metabolism of sugar, fat and protein, penetrates the cell membranes of cells in important organs, improves microcirculation, enables cells to continue metabolizing in an oxygen-deficient state, promotes the recovery of damaged cell functions, activates organ functions and enhances the body's immunity.

More

It promotes the metabolism of sugar, fat and protein, penetrates the cell membranes of cells in important organs, improves microcirculation, enables cells to continue metabolizing in an oxygen-deficient state, promotes the recovery of damaged cell functions, activates organ functions and enhances the body's immunity.

11070-73-8 3
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.